Alex Arrow

Track

Insider profile

Currently holds a position at Protagenic Therapeutics Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Acting Chief Financial Officer Protagenic Therapeutics Inc Feb. 12, 2016 -
Chief Medical Officer BIOLASE Inc Sept. 2, 2014 - Dec. 1, 2014
President, Chief Operating Officer BIOLASE Inc Feb. 28, 2014 - Sept. 2, 2014
President, Chief Operating Officer, Director BIOLASE Inc June 6, 2013 - Feb. 28, 2014
Independent Director BIOLASE Inc July 17, 2010 - June 6, 2013
Alex Arrow's trades of Protagenic Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
395.64
Quantity 40,714 +4.0%
Value US$1,307,666
Transaction date
Purchase
Price
377.77
Quantity 13,648 -45.8%
Value US$663,925
Transaction date
Purchase
Price
462.85
Quantity 42,821 +24.5%
Value US$3,016,917
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-13 2023-10-12
B Purchase
40,714 +4.0%
395.64
US$1,307,666 		40,714 +4.0% 395.64 US$1,307,666
2022-05-18 2022-05-18
B Purchase
13,648 -45.8%
377.77
US$663,925 		13,648 -45.8% 377.77 US$663,925
2022-05-18 2022-05-17
B Purchase
42,821 +24.5%
462.85
US$3,016,917 		42,821 +24.5% 462.85 US$3,016,917
2021-05-03 2021-04-30
B Purchase
1,000 +0.8%
2.29
US$2,290 		1,000 +0.8% 2.29 US$2,290
2021-05-03 2021-04-29
B Purchase
1,000 +0.8%
2.29
US$2,290 		1,000 +0.8% 2.29 US$2,290